Wu, W., Wang, J., Xiao, C., Su, Z., Su, H., Zhong, W., . . . Zhu, Y. Z. (2021). SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases. Wiley.
Cita Chicago Style (17a ed.)Wu, Weijun, Jinghuan Wang, Chenxi Xiao, Zhenghua Su, Haibi Su, Wen Zhong, Jianchun Mao, Xinhua Liu, y Yi Zhun Zhu. SMYD2‐mediated TRAF2 Methylation Promotes the NF‐κB Signaling Pathways in Inflammatory Diseases. Wiley, 2021.
Cita MLA (8a ed.)Wu, Weijun, et al. SMYD2‐mediated TRAF2 Methylation Promotes the NF‐κB Signaling Pathways in Inflammatory Diseases. Wiley, 2021.
Precaución: Estas citas no son 100% exactas.